Donald J. Hayden Jr., Director at REGENXBIO Inc. (RGNX), sold 60,000 shares at $22.43 ($1.3M) on 2017-05-01, disclosed to the SEC on 2017-05-03.
Open-market sale of $1.3M RGNX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.34 | 4,738 | $101K | 7.6% |
| 2 | $21.34 | 4,738 | $101K | 7.6% |
| 3 | $22.43 | 25,262 | $567K | 42.4% |
| 4 | $22.43 | 25,262 | $567K | 42.4% |
| Total | $22.26 avg | 60,000 | $1.3M | 100% |
| Filing → |
| RGNX | SELL | 2020-02-07 | $100K | — | Filing → |
| RGNX | SELL | 2020-01-21 | $160K | — | Filing → |
| RGNX | SELL | 2020-01-16 | $1.4M | — | Filing → |